Facet-Joint Injection Market Expansion Is Reshaping Competitive Dynamics Across The Industry
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Facet-Joint Injection Market Growth From $3.17 Billion In 2026 To $4.1 Billion By 2030 At A CAGR Of 6.6%
The facet-joint injection market has seen notable expansion over the past few years. From a valuation of $2.97 billion in 2025, it is projected to climb to $3.18 billion by 2026, representing a compound annual growth rate (CAGR) of 6.9%. This upward trajectory during the historical timeframe was largely driven by factors such as the rising prevalence of spinal degeneration, higher rates of arthritis, growing awareness around pain management practices, the widespread application of corticosteroids, and an increase in the number of outpatient procedures.
Projections for the facet-joint injection market indicate robust expansion in the coming years. By 2030, its value is anticipated to reach $4.1 billion, reflecting a compound annual growth rate (CAGR) of 6.6%. This upward trajectory during the forecast timeframe is fueled by factors such as an aging demographic, a growing preference for minimally invasive treatments, the widespread occurrence of chronic pain, the broadening of ambulatory care services, and the utilization of imaging-guided interventions. Key developments shaping the forecast period include an escalating demand for low-invasive pain procedures, heightened application in treating chronic back pain, the proliferation of outpatient pain management centers, the integration of image-guided injection methodologies, and the increasing number of ambulatory surgical facilities.
Download A Free Sample Report For Comprehensive Market Insights:
Facet-Joint Injection Market Growth Momentum: Which Factors Are Influencing Demand?
The increasing occurrence of spinal disorders and chronic back ailments is anticipated to boost the expansion of the facet-joint injection market in the coming period. Spinal disorders and chronic back ailments describe prolonged conditions impacting the spine, including disc degeneration, arthritis, or nerve impingement, which result in ongoing pain, restricted movement, and a diminished quality of life. The growing frequency of spinal disorders and chronic back ailments stems from inactive lifestyles and poor posture habits, prompting individuals to pursue effective, minimally disruptive therapies that alleviate persistent pain and restore functional movement. Facet-joint injection aids spinal disorders and chronic back ailments by decreasing pain and swelling in the spine, offering relief to individuals affected by the rising issue of spinal conditions and chronic back pain. For example, in May 2023, based on data from Spinal Cord Inc., a US-based nonprofit resource center, approximately 18,000 new spinal cord injury (SCI) cases are documented each year in the United States, with around 302,000 people currently residing with spinal cord injuries across the nation. Thus, the increasing frequency of spinal disorders and chronic back ailments is fueling the advancement of the facet-joint injection market.
The escalating inclination toward minimally invasive techniques is anticipated to drive the growth of the facet-joint injection market in the future. Minimally invasive techniques denote medical procedures conducted via small incisions or without necessitating extensive surgical openings. The rise in minimally invasive techniques is fueled by patients’ growing desire for quicker recovery periods and lessened postoperative discomfort. Facet-joint injection improves minimally invasive techniques by delivering precise pain management and diagnostic clarity while avoiding major surgical involvement. For instance, in 2023, the American Society of Plastic Surgeons, a US-based specialty organization, reported that the overall count of minimally invasive cosmetic procedures increased from 23.7 million in 2022 to 25.4 million in 2023. Consequently, the rising demand for minimally invasive techniques is propelling the growth of the facet-joint injection market.
Facet-Joint Injection Market Categorization By Product Type And Application
The facet-joint injection market covered in this report is segmented –
1) By Product Type: Corticosteroids, Local Anesthetics, Hyaluronic Acid, Other Product Types
2) By Application: Cervical Facet Joints, Thoracic Facet Joints, Lumbar Facet Joints
3) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users
Subsegments:
1) By Corticosteroids: Triamcinolone Acetonide, Methylprednisolone Acetate, Dexamethasone Sodium Phosphate, Betamethasone
2) By Local Anesthetics: Lidocaine, Bupivacaine, Ropivacaine, Prilocaine
3) By Hyaluronic Acid: High Molecular Weight Hyaluronic Acid, Low Molecular Weight Hyaluronic Acid, Cross-Linked Hyaluronic Acid, Non-Cross-Linked Hyaluronic Acid
4) By Other Product Types: Platelet-Rich Plasma, Biological Agents, Combination Formulations
Facet-Joint Injection Market Trends Reshaping Industry Growth
Leading players in the facet-joint injection market are concentrating on creating advanced solutions, such as facet fusion systems, designed to deliver sustained pain relief and enhance therapeutic results. Facet fusion systems are specialized medical implants used to stabilize and unite the spine’s facet joints through the promotion of bone growth between adjacent vertebrae. A notable example occurred in March 2025, when Aurora Spine Corporation, a medical device firm based in the United States, secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its latest innovation—the AEROTM Facet Fusion System. This system employs a titanium plasma spray coating to facilitate better osseointegration and fusion capability. It accommodates a range of implant sizes to suit diverse patient anatomies and features radiolucent instrumentation that improves visibility during surgery. These attributes are collectively intended to boost procedural efficiency and long-term outcomes in addressing chronic back pain stemming from facet joint disorders.
Facet-Joint Injection Market Company Landscape And Strategic Competition
Major companies operating in the facet-joint injection market are Abbott Laboratories, B. Braun Melsungen AG, BD (Becton Dickinson and Company), Cook Medical, Teleflex Incorporated, Merit Medical Systems Inc., Halyard Health, ICU Medical Inc., Pajunk GmbH Medizintechnologie, Avanos Medical Inc., Vygon SA, Cardinal Health Inc., Terumo Corporation, Nipro Corporation, Septodont Holding, Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Zydus Lifesciences Ltd., Amneal Pharmaceuticals LLC, Lupin Limited, Piramal Pharma Limited, Intas Pharmaceuticals Ltd., Gland Pharma Limited, Amphastar Pharmaceuticals Inc., Fresenius Medical Care, Baxter International Inc., McKesson Corporation
Access The Complete Facet-Joint Injection Market Report:
Facet-Joint Injection Market Geographic Distribution And Regional Opportunities
North America was the largest region in the facet-joint injection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the facet-joint injection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
